Skip to content
Open access

Association Between the GGT/HDL-C Ratio and Ultrasonography-Defined NAFLD in Vietnamese Adults: A Cross-Sectional Study

Aug 2026 · Journal of Personalized Medicine · Vol 16, pp. 441 · 0 citations · 27 references
Medicine

TL;DR

The GGT/HDL-C ratio showed a significant unadjusted association with NAFLD and moderate discriminatory performance, however, because the association was no longer significant after full adjustment, it should currently be considered a simple laboratory-based screening marker that requires further validation before routine clinical application.

Abstract

Background and aims. Nonalcoholic fatty liver disease (NAFLD) is a prevalent chronic liver disease associated with cirrhosis, hepatocellular carcinoma, and increased risks of liver-related and cardiovascular mortality. Many patients, however, remain asymptomatic until advanced stages. The gamma-glutamyl transferase to high-density lipoprotein cholesterol (GGT/HDL-C) ratio is a simple, noninvasive marker reflecting hepatic dysfunction and cardiometabolic imbalance. This study assessed its association with NAFLD and determined an optimal cutoff for identifying NAFLD. Methods. We conducted a cross-sectional analysis of 575 adults undergoing routine health examinations at the University of Medicine and Pharmacy Hospital in Ho Chi Minh City between 2021 and 2023. Participants with significant alcohol intake, viral hepatitis, or other chronic liver diseases were excluded. NAFLD was diagnosed by standardized abdominal ultrasonography based on increased hepatic echogenicity relative to the renal cortex or spleen. Associations between GGT/HDL-C and NAFLD were assessed by logistic regression (both as a continuous variable and by quartiles), and diagnostic performance was evaluated using receiver operating characteristic (ROC) analysis. Statistical significance was defined as a two-tailed p-value < 0.05. Results. Individuals with NAFLD showed significantly higher BMI, prevalence of hypertension and diabetes, and elevated glucose, HbA1c, AST, ALT, GGT, cholesterol, triglycerides, and LDL-C, along with lower HDL-C. Each unit increase in the GGT/HDL-C ratio was associated with a 2% increase in the odds of NAFLD based on univariate logistic regression analysis. However, after adjustment for demographic and metabolic covariates, the GGT/HDL-C ratio was no longer independently associated with NAFLD. The highest quartile had an odds ratio of 7.05 (95% CI: 4.2–11.83) compared to the lowest. The area under the ROC curve for GGT/HDL-C was 0.72, outperforming GGT or HDL-C alone. A cutoff of 32.47 UI/mmol had 72.4% sensitivity and 63.3% specificity. Conclusions. The GGT/HDL-C ratio showed a significant unadjusted association with NAFLD and moderate discriminatory performance. However, because the association was no longer significant after full adjustment, the ratio should currently be considered a simple laboratory-based screening marker that requires further validation before routine clinical application.

Read PDF

Similar papers

Open access Aug 2026

Association Between Gamma-Glutamyl Transferase Levels and Framingham-Estimated Cardiovascular Risk in Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study

Background: Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver test derangement and is closely linked to metabolic syndrome. Patients with NAFLD show a higher burden of cardiovascular risk factors than the general population. Gamma-glutamyl transferase (GGT), routinely measured as part of the...

M. Deepak, S. Kumar, R. Elanchezian · 0 citations
Open access Aug 2026

Triglyceride-to-HDL Cholesterol Ratio is Associated with Hepatic Steatosis but not Fibrosis in Patients with Severe Obesity: A Cross-Sectional Study

Metabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent among individuals with severe obesity. The triglyceride-to-high-density lipoprotein cholesterol ratio (TG/HDL-C) is an accessible surrogate marker of insulin resistance, but its association with hepatic steatosis and fibrosis in candid...

Carolina de Oliveira Bernardes, Esdras Marques Lins, Fernanda Appolônio Rocha et al. · 0 citations
Open access Sep 2026

Serum Uric Acid/Creatinine Ratio as a Potential Biomarker for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes

Background: One of the predominant diseases among patients suffering from Type 2 diabetes mellitus (T2DM) is non-alcoholic fatty liver disease (NAFLD). Finding reliable biomarkers for predicting NAFLD severity is required for early intervention and prevention of further diseases such as fibrosis, hepatocellular cancer,...

V. Honnapurmath, H. Sarma · 0 citations
Open access Oct 2026

Association between the fasting blood glucose to high-density lipoprotein cholesterol ratio and non-alcoholic fatty liver disease in Chinese adults: a secondary analysis

Elevated fasting blood glucose (FBG) and decreased high-density lipoprotein cholesterol (HDL-C) are individually associated with non-alcoholic fatty liver disease (NAFLD). This study investigated whether their composite ratio (GHR) is independently associated with NAFLD and whether this association varies across su...

Da-Gang Lin, Geng-Bin Lin, Zhe Liu · 0 citations
Open access Aug 2026

Joint associations of lipoprotein(a) and systemic inflammatory indices with FibroTouch-derived hepatic steatosis and liver stiffness in Chinese adults

Among Chinese adults, higher circulating Lp(a) was inversely associated with FibroTouch-derived hepatic steatosis and liver stiffness and combining Lp(a) with systemic inflammatory indices may provide complementary information for noninvasive cross-sectional assessment.

De-Jing Huang, Zhong-Hua Sun, Xiaolong Shen et al. · 0 citations
Open access Sep 2026

Impact of Obesity on Biochemical Parameters and the Association Between NAFLD and Type 2 Diabetes Mellitus: A Retrospective Study

Background: Non-alcoholic fatty liver disease (NAFLD), now termed metabolic dysfunction-associated steatotic liver disease (MASLD), is strongly associated with obesity, insulin resistance and type 2 diabetes mellitus (T2DM). Obesity and T2DM may contribute to hepatic steatosis, abnormal liver enzymes and atherogenic dy...

R. Rana, Moeez Zafar, Mariam Iqbal et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.